These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19939637)

  • 21. Combination antimicrobial treatment versus monotherapy: the contribution of meta-analyses.
    Paul M; Leibovici L
    Infect Dis Clin North Am; 2009 Jun; 23(2):277-93. PubMed ID: 19393909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of inhaled antibiotics in cystic fibrosis patients.
    Wunderlich P; Paul KD; Wehner J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):34-6. PubMed ID: 2130713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery systems to increase the selectivity of antibiotics in phagocytic cells.
    Briones E; Colino CI; Lanao JM
    J Control Release; 2008 Feb; 125(3):210-27. PubMed ID: 18077047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
    Louie TJ
    CMAJ; 1994 Mar; 150(5):669-76. PubMed ID: 8313286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial drug delivery in food animals and microbial food safety concerns: an overview of in vitro and in vivo factors potentially affecting the animal gut microflora.
    Yan SS; Gilbert JM
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1497-521. PubMed ID: 15191795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rational use of antibiotics to treat respiratory tract infections.
    File TM; Hadley JA
    Am J Manag Care; 2002 Aug; 8(8):713-27. PubMed ID: 12212759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial resistance to antibiotics in acute respiratory infections (ARIs).
    López-Antuñano FJ; Silva-Sánchez J
    Arch Med Res; 1997; 28(2):195-203. PubMed ID: 9204608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic use in cystic fibrosis.
    Eisenberg JD
    Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cystic fibrosis: current therapy. Inhalation antibiotics].
    Mordasini C
    Schweiz Med Wochenschr Suppl; 2000; 122():43S-44S. PubMed ID: 12536472
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhaled formulations and pulmonary drug delivery systems for respiratory infections.
    Zhou QT; Leung SS; Tang P; Parumasivam T; Loh ZH; Chan HK
    Adv Drug Deliv Rev; 2015 May; 85():83-99. PubMed ID: 25451137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The future of inhaled antibiotic therapy. New products].
    Vendrell Relat M; Muñoz Castro G; Sabater Talaverano G; De Gracia Roldán J
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():30-2. PubMed ID: 21703477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled Antibiotics for Gram-Negative Respiratory Infections.
    Wenzler E; Fraidenburg DR; Scardina T; Danziger LH
    Clin Microbiol Rev; 2016 Jul; 29(3):581-632. PubMed ID: 27226088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomes as delivery systems for antibiotics.
    Drulis-Kawa Z; Dorotkiewicz-Jach A
    Int J Pharm; 2010 Mar; 387(1-2):187-98. PubMed ID: 19969054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists.
    Le J; Ashley ED; Neuhauser MM; Brown J; Gentry C; Klepser ME; Marr AM; Schiller D; Schwiesow JN; Tice S; VandenBussche HL; Wood GC;
    Pharmacotherapy; 2010 Jun; 30(6):562-84. PubMed ID: 20500046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.
    Moreno-Sastre M; Pastor M; Salomon CJ; Esquisabel A; Pedraz JL
    J Antimicrob Chemother; 2015 Nov; 70(11):2945-55. PubMed ID: 26203182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges and strategies in drug delivery systems for treatment of pulmonary infections.
    Ho DK; Nichols BLB; Edgar KJ; Murgia X; Loretz B; Lehr CM
    Eur J Pharm Biopharm; 2019 Nov; 144():110-124. PubMed ID: 31493510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections.
    Merchant Z; Buckton G; Taylor KM; Stapleton P; Saleem IY; Zariwala MG; Somavarapu S
    Curr Pharm Des; 2016; 22(17):2577-98. PubMed ID: 26983671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives.
    Sugianto TD; Chan HK
    Expert Opin Drug Deliv; 2016; 13(1):7-22. PubMed ID: 26289675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
    Velkov T; Abdul Rahim N; Zhou QT; Chan HK; Li J
    Adv Drug Deliv Rev; 2015 May; 85():65-82. PubMed ID: 25446140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.